Literature DB >> 26540435

Role of Bai-Shao towards the antidepressant effect of Chaihu-Shu-Gan-San using metabonomics integrated with chemical fingerprinting.

Xing Chang1, Hongmei Jia1, Chao Zhou1, Hongwu Zhang1, Meng Yu1, Junshan Yang1, Zhongmei Zou2.   

Abstract

Chaihu-Shu-Gan-San (CSGS) is a classical traditional Chinese medicine formula for the treatment of depression. As one of the single herbs in CSGS, Bai-Shao displayed antidepressant effect. In order to explore the role of Bai-Shao towards the antidepressant effect of CSGS, the metabolic regulation and chemical profiles of CSGS with and without Bai-Shao (QBS) were investigated using metabonomics integrated with chemical fingerprinting. At first, partial least squares regression (PLSR) analysis was applied to characterize the potential biomarkers associated with chronic unpredictable mild stress (CUMS)-induced depression. Among 46 differential metabolites found in the ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-Q-TOF/MS) and (1)H NMR-based urinary metabonomics, 20 were significantly correlated with the preferred sucrose consumption observed in behavior experiments and were considered as biomarkers to evaluate the antidepressant effect of CSGS. Based on differential regulation on CUMS-induced metabolic disturbances with CSGS and QBS treatments, we concluded that Bai-Shao made crucial contribution to CSGS in the improvement of the metabolic deviations of six biomarkers (i.e., glutamate, acetoacetic acid, creatinine, xanthurenic acid, kynurenic acid, and N-acetylserotonin) disturbed in CUMS-induced depression. While the chemical constituents of Bai-Shao contributed to CSGS were paeoniflorin, albiflorin, isomaltopaeoniflorin, and benzoylpaeoniflorin based on the multivariate analysis of the UPLC-Q-TOF/MS chemical profiles from CSGS and QBS extracts. These findings suggested that Bai-Shao played an indispensable role in the antidepressant effect of CSGS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active constituents; Bai-Shao; Chaihu-Shu-Gan-San; Chemical fingerprinting; Integrated strategy; Urinary metabonomics

Mesh:

Substances:

Year:  2015        PMID: 26540435     DOI: 10.1016/j.jchromb.2015.10.007

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

Review 1.  Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review.

Authors:  Dan-Dan Feng; Tao Tang; Xiang-Ping Lin; Zhao-Yu Yang; Shu Yang; Zi-An Xia; Yun Wang; Piao Zheng; Yang Wang; Chun-Hu Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-20       Impact factor: 2.570

2.  Study of Antidepressant-Like Effects of Albiflorin and Paeoniflorin Through Metabolomics From the Perspective of Cancer-Related Depression.

Authors:  Danping Zhao; Jianjun Zhang; Yingli Zhu; Cheng He; Wenting Fei; Na Yue; Chenglong Wang; Linyuan Wang
Journal:  Front Neurol       Date:  2022-07-08       Impact factor: 4.086

3.  Integrating Metabolomics and Network Analysis for Exploring the Mechanism Underlying the Antidepressant Activity of Paeoniflorin in Rats With CUMS-Induced Depression.

Authors:  Chaofang Lei; Zhigang Chen; Lili Fan; Zhe Xue; Jianbei Chen; Xihong Wang; Zhen Huang; Yinian Men; Mingzhi Yu; Yueyun Liu; Jiaxu Chen
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

4.  Effects of Platycodins Folium on Depression in Mice Based on a UPLC-Q/TOF-MS Serum Assay and Hippocampus Metabolomics.

Authors:  Cuizhu Wang; Hongqiang Lin; Na Yang; Han Wang; Yan Zhao; Pingya Li; Jinping Liu; Fang Wang
Journal:  Molecules       Date:  2019-05-02       Impact factor: 4.411

5.  Antidepression and Prokinetic Effects of Paeoniflorin on Rats in the Forced Swimming Test via Polypharmacology.

Authors:  Dao-Zhou Mu; Mei Xue; Jian-Jun Xu; Ying Hu; Yi Chen; Ping Ren; Xi Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.